Regulatory effect and mechanism of gastrin and its antagonists on colorectal carcinoma

Table 7 Expression of gastrin, c-myc, c-fos, rasp21 and AgNORs in different pathological carcinoma tissue

Group	n	Gastrin positive (%)	c-myc positive (%)	c-fos positive (%)	rasp21 positive (%)	AgNORs
Highly-differentiated	26	14 (53.9)a	15 (57.7)	13 (50.0)	15 (57.7)	7.12 ± 1.80
Moderately-differentiated	12	4 (33.3)	5 (41.7)	7 (58.3)	6 (50.0)	7.25 ± 0.86
Poorly- and mucinous	10	1 (10.0)	6 (60.0)	3 (30.0)	5 (50.0)	7.11 ± 1.20

^aP < 0.05 vs poorly-differentiated and mucinous group.